Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Guanabenz in Bone Metastasis
NCT02443103Terminated
- Start
- May 2015
- Primary completion
- Jun 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of guanabenz in bone metastasis. Primary endpoint: Bone Formation and Bone Resorption Markers at 12 weeks. Started May 2015; status: terminated.
02
Drugs
guanabenz
03
Conditions
bone metastasis
Beyond the preview
Go deeper on NCT02443103.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02443103.